SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 15.85% to Rs. 12220.60 millions for the quarter ended September 2021 as compared to Rs. 10548.50 millions during the corresponding quarter last year.A humble growth in net profit of 6.42% reported in the quarter ended September 2021 to Rs. 1923.30  millions from Rs. 1807.30 millions.The company reported a good operating profit of 2779.00 millions compared to 2627.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 12220.60 10548.50 15.85 24398.90 21191.20 15.14 43100.20 40931.40 5.30
Other Income 182.10 220.60 -17.45 374.20 496.90 -24.69 809.00 1143.90 -29.28
PBIDT 2779.00 2627.70 5.76 5622.60 5238.20 7.34 10023.60 8708.40 15.10
Interest 45.10 47.90 -5.85 95.50 92.40 3.35 182.80 85.30 114.30
PBDT 2733.90 2579.80 5.97 5527.10 5145.80 7.41 9840.80 8623.10 14.12
Depreciation 162.00 142.90 13.37 319.30 283.90 12.47 581.30 596.10 -2.48
PBT 2571.90 2436.90 5.54 5207.80 4861.90 7.11 9259.50 8027.00 15.35
TAX 648.60 629.60 3.02 1326.90 1251.10 6.06 2352.60 2097.70 12.15
Deferred Tax -41.60 -19.50 113.33 -69.40 -34.00 104.12 -37.90 14.70 -357.82
PAT 1923.30 1807.30 6.42 3880.90 3610.80 7.48 6906.90 5929.30 16.49
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 22.74 24.91 -8.71 23.04 24.72 -6.77 23.26 21.28 9.31

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×